Evidence map›Paper›PMID 32894041›Full record

ArticleBMC bioinformatics2020

A systematic study of critical miRNAs on cells proliferation and apoptosis by the shortest path.

Peng Xu, Qian Wu, Deyang Lu, Jian Yu, Yongsheng Rao, Zheng Kou, Gang Fang, Wenbin Liu, Henry Han

Open access · goldAbstract read
In one paragraph

Article in BMC bioinformatics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. MicroRNAs Regulate Function in Atherosclerosis and Clinical Implications.Oxidative medicine and cellular longevity · 2023
    Review
  9. Review
  10. Article
  11. Frontiers in pharmacology · 2022
    Review
  12. Recombinant proteinWorld journal of gastroenterology · 2021
    Article
  13. Article
  14. Article
  15. New Insights into LINC00346 and its Role in Disease.Frontiers in cell and developmental biology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Peng XuInstitute of computational science and technology, Guangzhou University, Guangzhou, 510006, Guangdong, China.
Qian WuCollege of Computer Science and Artificial Intelligence, Wenzhou University, Wenzhou, 325035, China.
Deyang LuInstitute of computational science and technology, Guangzhou University, Guangzhou, 510006, Guangdong, China.
Jian YuInstitute of computational science and technology, Guangzhou University, Guangzhou, 510006, Guangdong, China.
Yongsheng RaoInstitute of computational science and technology, Guangzhou University, Guangzhou, 510006, Guangdong, China.
Zheng KouInstitute of computational science and technology, Guangzhou University, Guangzhou, 510006, Guangdong, China.
Gang FangInstitute of computational science and technology, Guangzhou University, Guangzhou, 510006, Guangdong, China.
Wenbin LiuInstitute of computational science and technology, Guangzhou University, Guangzhou, 510006, Guangdong, China. wbliu6910@gzhu.edu.cn.ORCID http://orcid.org/0000-0001-9091-3177
Henry HanDepartment of Computer and Information Science, Fordham University, New York, NY, 10023, USA. xhan9@fordham.edu.
Guangzhou University · CNFordham University · USWenzhou University · CN

Funding

National Natural Science Foundation of China 61572367National Natural Science Foundation of China 61972107National Natural Science Foundation of China 61972109
6 · The paper itself

Abstract

backgroundMicroRNAs are a class of important small noncoding RNAs, which have been reported to be involved in the processes of tumorigenesis and development by targeting a few genes. Existing studies show that the imbalance between cell proliferation and apoptosis is closely related to the initiation and development of cancers. However, the impact of miRNAs on this imbalance has not been studied systematically.

resultsIn this study, we first construct a cell fate miRNA-gene regulatory network. Then, we propose a systematical method for calculating the global impact of miRNAs on cell fate genes based on the shortest path. Results on breast cancer and liver cancer datasets show that most of the cell fate genes are perturbed by the differentially expressed miRNAs. Most of the top-identified miRNAs are verified in the Human MicroRNA Disease Database (HMDD) and are related to breast and liver cancers. Function analysis shows that the top 20 miRNAs regulate multiple cell fate related function modules and interact tightly based on their functional similarity. Furthermore, more than half of them can promote sensitivity or induce resistance to some anti-cancer drugs. Besides, survival analysis demonstrates that the top-ranked miRNAs are significantly related to the overall survival time in the breast and liver cancers group.

conclusionIn sum, this study can help to systematically study the important role of miRNAs on proliferation and apoptosis and thereby uncover the key miRNAs during the process of tumorigenesis. Furthermore, the results of this study will contribute to the development of clinical therapy based miRNAs for cancers.

Indexed as

ApoptosisBiomarkersBreast NeoplasmsCell ProliferationDatabases, GeneticFemaleGene Regulatory NetworksHumansLiver NeoplasmsMicroRNAsRNA, MessengerSurvival AnalysisBiomarkersMicroRNAsRNA, MessengerApoptosisCancerCell fate geneImbalancemiRNAProliferation

Identifiers

PMID32894041
PMCPMC7487489
OpenAlexW3083336770

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.